Upload
Featured Recent Articles Topics Login Upload

Search Results for '100 hcv'

100 hcv published presentations and documents on DocSlides.

Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Performance evaluation of the Hologic
Performance evaluation of the Hologic
by ariel
Aptima. HCV Quant . Dx. assay for detection of H...
C-EDGE Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Breakout session Ryan White
Breakout session Ryan White
by lydia
Marion Peters. August 2020. ARS Question 1:. Which...
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...
NS5A and polymerase inhibitors
NS5A and polymerase inhibitors
by LoveBug
Mark Sulkowski, MD. Professor of Medicine. Johns H...
State of the Art Therapy for HCV
State of the Art Therapy for HCV
by liane-varnes
Last Updated: February . 21, 2014. Robert G. Gish...
Are (exogenous) interferons
Are (exogenous) interferons
by amey
really necessary?. Peter . Ferenci. Medical Univer...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Webinar presented by : ANDES
Webinar presented by : ANDES
by teresa
Prediction. . of . events. . after. ART. initia...
≥ 18 years, HCV genotype 1-6
≥ 18 years, HCV genotype 1-6
by karlyn-bohler
≥ 18 years, HCV genotype 1-6 HCV RNA > 1 00...
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
ION-4
ION-4
by briana-ranney
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
Ledipasvir-Sofosbuvir in GT-1
Ledipasvir-Sofosbuvir in GT-1
by faustina-dinatale
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
C-SCAPE
C-SCAPE
by tawny-fly
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
C-SCAPE
C-SCAPE
by pasty-toler
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
SIRIUS
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
SOF/VEL
SOF/VEL
by lois-ondreau
400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...